The novel treatment of the medication represents a major development in the care of type 2 diabetes. Distinct from existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide916559.bloggactivo.com/41048202/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment